Jindan Yu
Impact in
- Cell Biology top 0.05%
- Hippo pathway signaling and YAP/TAZ
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
Papers in
-
- Prostate Cancer Treatment and Research 39
-
- Cancer-related molecular mechanisms research 11
- Co-authors
- Bin ZhaoKun‐Liang GuanLi LiArul M. ChinnaiyanWeiquan LiZhi-Chun LaiCun-Yu WangJonathan C. Zhao
- Journals
- Cancer Research (13 papers)Oncogene (8 papers)Genes & Development (5 papers)Neoplasia (4 papers)Nature Communications (4 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Jindan Yu
84 papers receiving 12.6k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Cell Biology 5.2k
- Cancer Research 2.8k
- Molecular Biology 8.9k
- Pulmonary and Respiratory Medicine 2.4k
- Oncology 1.6k
Countries citing papers authored by Jindan Yu
This map shows the geographic impact of Jindan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jindan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jindan Yu more than expected).
Fields of papers citing papers by Jindan Yu
This network shows the impact of papers produced by Jindan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jindan Yu. The network helps show where Jindan Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jindan Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 15 | |
| 3 | 2022 | 24 | |
| 4 | 2022 | 36 | |
| 5 | 2021 | 46 | |
| 6 | 2019 | 92 | |
| 7 | 2018 | 17 | |
| 8 | 2018 | 156 | |
| 9 | 2018 | 42 | |
| 10 | 2018 | 63 | |
| 11 | 2017 | 77 | |
| 12 | 2013 | 117 | |
| 13 | 2013 | 65 | |
| 14 | 2011 | 73 | |
| 15 | 2010 | 87 | |
| 16 | 2010 | 82 | |
| 17 | Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer Hit paper breakdown → | 2008 | 833 |
| 18 | 2008 | 121 | |
| 19 | 2007 | 73 | |
| 20 | 2007 | 251 |
About Jindan Yu
Jindan Yu is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Cell Biology and Immunology and Allergy, having authored 87 papers that have together received 12.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (39 papers), Epigenetics and DNA Methylation (21 papers), Cancer-related gene regulation (20 papers), Cancer-related molecular mechanisms research (11 papers), Ubiquitin and proteasome pathways (10 papers), Genomics and Chromatin Dynamics (9 papers), Hippo pathway signaling and YAP/TAZ (8 papers) and FOXO transcription factor regulation (7 papers). The work is most often cited by research in Cell Biology (5.2k citations), Cancer Research (2.8k citations), Molecular Biology (8.9k citations), Pulmonary and Respiratory Medicine (2.4k citations) and Oncology (1.6k citations). Jindan Yu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Bin Zhao, Kun‐Liang Guan, Li Li, Arul M. Chinnaiyan, Weiquan Li, Zhi-Chun Lai, Arul M. Chinnaiyan, Cun-Yu Wang, Jonathan C. Zhao and Joungmok Kim. Their work appears in journals such as Cancer Research, Oncogene, Genes & Development, Neoplasia and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.